Your browser doesn't support javascript.
loading
Expression of TRAIL (Apo-2L)/TRAIL Receptor System Related to Apoptosis at the Human Extraembryonic Tissues and Gestational Trophoblastic Disease / 대한산부인과학회잡지
Korean Journal of Obstetrics and Gynecology ; : 2156-2161, 2003.
Article in Korean | WPRIM | ID: wpr-79243
ABSTRACT
Human uterus has been known as a immune privileged site for the product of conception. At the feto-maternal interface, Fas system is a underlying main mechanism of maternal immune acceptance. To date, the TRAIL (TNF-related apoptosis-inducing ligand) system is known to be another pivotal mechanism.

OBJECTIVE:

To clarify the protein expression of TRAIL ligand and receptors in the normal and pathologic (preeclampsia, hydatidiform mole) placenta, chorioamnion, decidua.

METHODS:

we investigated the expression of TRAIL system in the above-mentioned tissues by using Western Hybridization.

RESULTS:

All tissues expressed TRAIL ligand and only a DcR2 among TRAIL receptors (DR4, DR5, DcR1, DcR2).

CONCLUSION:

we demonstrated the expression of TRAIL ligand and DcR2 protein at the feto-maternal interface of the normal and pathologic pregnancies. Further study regarding the expression of other receptors and quantitative analysis between normal and pathologic pregnancies should be followed.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Placenta / Uterus / Apoptosis / Decidua / Gestational Trophoblastic Disease / Receptors, TNF-Related Apoptosis-Inducing Ligand / Fertilization Limits: Female / Humans / Pregnancy Language: Korean Journal: Korean Journal of Obstetrics and Gynecology Year: 2003 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Placenta / Uterus / Apoptosis / Decidua / Gestational Trophoblastic Disease / Receptors, TNF-Related Apoptosis-Inducing Ligand / Fertilization Limits: Female / Humans / Pregnancy Language: Korean Journal: Korean Journal of Obstetrics and Gynecology Year: 2003 Type: Article